Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NQO1 | P15559 | 1/20 | 0.67 |
| ▸ | CA2 | P00918 | 4/20 | 0.50 |
| ▸ | CA12 | O43570 | 3/20 | 0.50 |
| ▸ | CA1 | P00915 | 3/20 | 0.50 |
| ▸ | CA7 | P43166 | 3/20 | 0.50 |
| ▸ | CA9 | Q16790 | 3/20 | 0.50 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.50 |
| ▸ | ACHE | P22303 | 1/20 | 0.50 |
| ▸ | IDO1 | P14902 | 1/20 | 0.48 |
| ▸ | CA4 | P22748 | 2/20 | 0.47 |
| ▸ | EP300 | Q09472 | 1/20 | 0.46 |
| ▸ | KAT8 | Q9H7Z6 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.44 |
| ▸ | IMPDH2 | P12268 | 1/20 | 0.43 |
| ▸ | IMPDH1 | P20839 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 3/20 | 0.42 |
| ▸ | MAPT | P10636 | 3/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6890763 | 0.85 | NQO1 (0.73) | NQO1CA2CA12CA1CA7 | |
| SCHEMBL9097639 | 0.85 | NQO1 (0.58) | NQO1CA2CA12CA1CA7 | |
| SCHEMBL1061836 | 0.81 | NQO1 (1.00) | NQO1CA2CA12CA1CA7 | |
| SCHEMBL29886321 | 0.81 | NQO1 (1.00) | NQO1CA2CA12CA1CA7 | |
| SCHEMBL11149087 | 0.79 | ACHE (0.62) | NQO1ACHEIDO1EP300KAT8 | |
| SCHEMBL1402631 | 0.79 | NQO1 (0.52) | NQO1CA2CA12CA1CA7 | |
| SCHEMBL30003276 | 0.79 | ACHE (0.62) | NQO1ACHEIDO1EP300KAT8 | |
| SCHEMBL15805518 | 0.79 | IMPDH2 (0.64) | NQO1ALDH1A1IMPDH2IMPDH1KDM4E | |
| SCHEMBL29380721 | 0.78 | IDO1 (0.73) | NQO1CA2CA12CA1CA7 | |
| SCHEMBL419307 | 0.78 | IDO1 (0.73) | NQO1CA2CA12CA1CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240335796-A1 | THIN-FILM COMPOSITE MEMBRANE AND METHODS OF MAKING AND USING THE SAME | THE PENN STATE RESEARCH FOUNDATION | 2024-10-10 | — | — | US | disclosed |
| US-12036515-B2 | Thin-film composite membrane and methods of making and using the same | THE PENN STATE RESEARCH FOUNDATION (PA) | 2024-07-16 | — | — | US | disclosed |
| US-20210370240-A1 | THIN-FILM COMPOSITE MEMBRANE AND METHODS OF MAKING AND USING THE SAME | THE PENN STATE RESEARCH FOUNDATION | 2021-12-02 | — | — | US | disclosed |
| EP-3860743-A1 | THIN-FILM COMPOSITE MEMBRANE AND METHODS OF MAKING AND USING THE SAME | The Penn State Research Foundation (US) | 2021-08-11 | — | — | EP | disclosed |
| WO-2020072594-A1 | THIN-FILM COMPOSITE MEMBRANE AND METHODS OF MAKING AND USING THE SAME | THE PENN STATE RESEARCH FOUNDATION (US) | 2020-04-09 | — | — | WO | disclosed |
| US-7655809-B2 | Compounds comprising a linear series of five fused carbon rings, and preparation thereof | UNIVERSITY OF OTTAWA (CA) | 2010-02-02 | — | — | US | disclosed |
| US-7655809-B2 | Compounds comprising a linear series of five fused carbon rings, and preparation thereof | UNIVERSITY OF OTTAWA (CA) | 2010-02-02 | — | — | US | disclosed |
| US-7655809-B2 | Compounds comprising a linear series of five fused carbon rings, and preparation thereof | UNIVERSITY OF OTTAWA (CA) | 2010-02-02 | — | — | US | disclosed |
| US-20050274945-A1 | Compounds comprising a linear series of five fused carbon rings, and preparation thereof | UNIVERSITY OF OTTAWA (CA) | 2005-12-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240335796-A1 | THIN-FILM COMPOSITE MEMBRANE AND METHODS OF MAKING AND USING THE SAME | PORCN, MLEC, FLOT1 | NQO1 4335/4885CA2 3089/4885CA12 1547/4885 |
| US-12036515-B2 | Thin-film composite membrane and methods of making and using the same | PORCN, MLEC, FLOT1 | NQO1 4335/4885CA2 3089/4885CA12 1547/4885 |
| US-20210370240-A1 | THIN-FILM COMPOSITE MEMBRANE AND METHODS OF MAKING AND USING THE SAME | PORCN, MLEC, FLOT1 | NQO1 4335/4885CA2 3089/4885CA12 1547/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.